Long-Term Survival of Patients with Lung Cancer Treated by Traditional Korean Medicine Combined with Western Treatment: Report of Two Cases
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Objectives: To evaluate the long-term survival effects of traditional Korean medicine (TKM) on refractory metastatic lung cancer and small cell lung cancer (SCLC), which have historically poor survival rates. Methods: A retrospective study was conducted using the medical records of two patients in Daejeon University hospital. The first patient, with SCLC, was treated from January 2000 to December 2009 and the other, with metastatic pulmonary cancer from primary hepatocellular carcinoma (HCC), was treated from September 2004 to February 2014. The patients were treated with herbal medicines at one-month intervals. During hospitalization, acupuncture and indirect moxibustion were performed concurrent with the administration of Western therapy. Treatment efficacy was assessed monthly using chest radiography, chest computed tomography, and laboratory examination data, and by measuring patient performance status. Results: Both patients exhibited a stable disease course for more than 9 years after the initial diagnosis of intractable lung cancer, suggesting that their disease status was controlled by TKM. Conclusions: We suggest that a combination of TKM with conventional Western therapy for refractory lung cancer patients is effective in controlling various symptoms related to lung cancer and improving quality of life, and may potentially prolong overall survival.
Abstract
Objectives: To evaluate the long-term survival effects of traditional Korean medicine (TKM) on refractory metastatic lung cancer and small cell lung cancer (SCLC), which have historically poor survival rates. Methods: A retrospective study was conducted using the medical records of two patients in Daejeon University hospital. The first patient, with SCLC, was treated from January 2000 to December 2009 and the other, with metastatic pulmonary cancer from primary hepatocellular carcinoma (HCC), was treated from September 2004 to February 2014. The patients were treated with herbal medicines at one-month intervals. During hospitalization, acupuncture and indirect moxibustion were performed concurrent with the administration of Western therapy. Treatment efficacy was assessed monthly using chest radiography, chest computed tomography, and laboratory examination data, and by measuring patient performance status. Results: Both patients exhibited a stable disease course for more than 9 years after the initial diagnosis of intractable lung cancer, suggesting that their disease status was controlled by TKM. Conclusions: We suggest that a combination of TKM with conventional Western therapy for refractory lung cancer patients is effective in controlling various symptoms related to lung cancer and improving quality of life, and may potentially prolong overall survival.
참고문헌 (19)
- Jemal A, "Cancer statistics, 2008", CA Cancer J Clin, 58, pp.71~96 (2008)
- Govindan R, "Changing epidemiology of small cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiology, and end results database", J Clin Oncol, 24, pp.4539~4544 (2006)
- Jackman DM, "Small cell lung cancer", Lancet, 366, pp.1385~1396 (2005)
- Patel AM, "Staging systems of lung cancer", Mayo Clin Proc, 68, pp.475~482 (1993)
- Kato Y, "Oat cell carcinoma of the lung: a review of 138 cases", Cancer, 23, pp.517~524 (1969)
- Honeybourne D, "Lung metastases from a primary hepatocellular carcinoma", Thorax, 35, pp.316~337 (1980)
- Uka K, "Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma", World J Gastroenterol, 13, pp.414~420 (2007)
- Jeong TY, "Prospective analysis on survival outcomes of nonsmall cell lung cancer stages over IIIb treated with HangAm-Dan", Chin J Lung Cancer, 13(11), pp.1009~1015 (2010)
- Jeong-seok Park, "Wheel Balance Cancer Therapy in the Treatment of Metastatic Gastric Carcinoma : A Retrospective Analysis of 62 Patients", 대한한방내과학회지, 28(3), pp.531~543 (2007), 대한한방내과학회
- Oken MM, "Toxicity and response criteria of the eastern cooperative oncology group", Am J Clin Oncol, 5, pp.649~655 (1982)
- Eisenhauer EA, "New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)", Eur J Cancer, 45, pp.228~247 (2009)
- 이동은, "항암단 및 그 주요 성분의 Calu6 와 MCF-7 사람 암세포주에 대한 항암효과", 대한한의학회지, 30(5), pp.50~60 (2009), 대한한의학회
- 유화승, "Two Cases of Endometrial Cancer Treated with Palliative Herbal Medication Hangam-dan (HAD)", 대한한의학회지, 28(4), pp.176~180 (2007), 대한한의학회
- Oh YS, "The effects of PSM on immune response", J Korean Oriental Med, 22(1), pp.46~52 (2001)
- Shin JW, "herbal formula, CGX, exerts hepatotherapeutic effects on dimethylnitrosamine -induced chronic liver injury model in rats", World J Gastroenterol, 12(38), pp.6142~6148 (2006)
- Sheehan J, "Radiosurgery for patients with recurrent small cell lung carcinoma metastatic to the brain:outcomes and prognostic factors", J Neurosurg (Suppl), 102, pp.247~254 (2005)
- Cohen MH, "Small cell bronchogenic carcinoma: A distinct clinicopathologic entity", Semin Oncol, 5(3), pp.234~238 (1978)
- Katyal S, "Extrahepatic metastases of hepatocellular carcinoma", Radiology, 216, pp.698~703 (2000)
- Choi JH, "Regression of small cell lung carcinoma by herbal medicine:A case with an 8-year follow-up", J Korean Oriental Oncol, 10(1), pp.87~89 (2005)